Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
390.00
-3.97 (-1.01%)
At close: Mar 27, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $313.54 billion as of March 27, 2026. Its market cap has increased by 16.21% in one year.
Market Cap
313.54B
Enterprise Value
340.90B
Revenue
79.90B
Ranking
n/a
PE Ratio
19.30
Stock Price
$390.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 313.54B, an increase of 3,479.80%. That is a compound annual growth rate of 11.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 313.54B | -5.42% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 789.71M |
| Glass House Brands | 694.63M |
| Elite Pharmaceuticals | 425.41M |
| American Oncology Network | 372.96M |
| CytoDyn | 370.51M |
| Northwest Biotherapeutics | 330.22M |
| Sofgen Pharma | 256.00M |